Noraini Ali - Millennium Pharmacon Commissioner
| SDPC Stock | IDR 143.00 4.00 2.72% |
Executive
Ms. Noraini binti Mohamed Ali serves as a Commissioner of PT Millennium Pharmacon International Tbk since May 23, 2012. She holds Bachelor degree in Finance and Accounting from Liverpool John Moores University, UK, and is a qualified accountant of the Association of Chartered Certified Accountants . She was a member of Company Audit Committee. Currently, she is member of Nomination and Remuneration, and Management Risk Committees. She was the Senior General Manager at Pharmaniaga Group Corporationrationrate Finance and was subsequently appointed as Procurement Director in April 2011. since 2012.
| Age | 47 |
| Tenure | 12 years |
| Phone | 62 21 270 85961 |
| Web | https://www.mpi-indonesia.co.id |
Millennium Pharmacon Management Efficiency
The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kok Goh | Hanjaya Mandala Sampoerna | 72 | |
| Harlina Tjandinegara | Barito Pacific Tbk | N/A | |
| Gatot Suwondo | Bank Rakyat Indonesia | 59 | |
| Niken Rachmad | Hanjaya Mandala Sampoerna | 69 | |
| Jeffry Wurangian | Bank Rakyat Indonesia | 61 | |
| Vincentius Loho | Bank Rakyat Indonesia | 60 | |
| Raden Pardede | Bank Central Asia | 58 | |
| Mahmud | Bank Rakyat Indonesia | 60 | |
| Susaningtyas Kertopati | Mnc Land Tbk | 52 | |
| Adhyaksa Dault | Bank Rakyat Indonesia | 53 | |
| Ike Andriani | Hanjaya Mandala Sampoerna | 45 | |
| Bambang Tribaroto | Bank Rakyat Indonesia | N/A | |
| Herbert Siahaan | Garuda Indonesia Persero | N/A | |
| Tonny Kusnadi | Bank Central Asia | 69 | |
| Rofikoh Rokhim | Bank Rakyat Indonesia | 48 | |
| Benny Butarbutar | Garuda Indonesia Persero | N/A | |
| Jefftry Wurangian | Bank Rakyat Indonesia | N/A | |
| Sigit Pramono | Bank Central Asia | 56 | |
| Hendricus Ivo | Bank Rakyat Indonesia | 60 | |
| Ikhsan Rosan | Garuda Indonesia Persero | N/A | |
| Isa Rachmatarwata | Garuda Indonesia Persero | 50 | |
Management Performance
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 |
Millennium Pharmacon Leadership Team
Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mohamad Hassan, F Director | ||
| Glenn Ariff, Unaffiliated Director | ||
| Aris, Chairman Audit | ||
| Dian Anggreni, Legal and Corporate Secretary | ||
| Ernie Hilal, Corporate Secretary | ||
| Yungkis Sucandra, Head Unit | ||
| Ahmad Bakar, Pres Director | ||
| Mohamad Mukhtar, President Director | ||
| Morsela, Ma Marketing | ||
| Puji Hartono, Head Unit | ||
| Nyoman Rai, Independent Commissioner | ||
| Dedi Martadiredja, Sr Sales | ||
| Ivan Hanafi, Independent Director | ||
| Olga Bolang, Co Sec | ||
| Noraini Ali, Commissioner | ||
| Izzat Othman, President Commissioner, Independent Commissioner | ||
| Yuni Arrivani, Deputy Legal | ||
| Mohamed Rahman, Commissioner |
Millennium Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Millennium Pharmacon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 828.27 B | |||
| Shares Outstanding | 1.27 B | |||
| Shares Owned By Insiders | 87.94 % | |||
| Shares Owned By Institutions | 3.35 % | |||
| Price To Earning | 9.31 X | |||
| Price To Book | 1.16 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Millennium Stock analysis
When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |